CORC

在结果中检索

CORC

浏览/检索结果: 共100条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Observation of large-scale anisotropy in the arrival directions of cosmic rays with LHAASO-KM2A 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Gao, Wei;  Cao, Qing;  Chen, Songzhan;  Cui, Shuwang;  He, Huihai
收藏  |  浏览/下载：16/0  |  提交时间：2023/01/16
Search for very high energy γ-ray emission from GRB 190829A with LHAASO-WCDA triggerless data 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Yao, Yuhua;  Liu, Wei;  Qiao, Bingqiang;  Guo, Yiqing;  Hu, Hongbo
收藏  |  浏览/下载：15/0  |  提交时间：2023/01/16
Remote Sensing Image Color Correction Method Based on Automatic Piecewise Polynomial Method 会议论文
Shenzhen, China, 2020-09-07
作者:  Chu, Nan-Qing;  Li, Xu-Yang;  Yi, Hong-Wei;  Ren, Zhi-Guang;  Ma, Zi-Xuan
收藏  |  浏览/下载：16/0  |  提交时间：2021/01/20
Complex ATP7B mutation patterns in Wilson disease and a evaluation of a yeast model for functional analysis of the individual variant 会议论文
作者:  Chen, Yongpeng;  Li, Xiaojin;  Zhang, Wei;  Zhou, Donghu;  Lv, Tingxia
收藏  |  浏览/下载：37/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：43/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：34/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05
Development of a plasma cell-free DNA chromosome instabilities assay for early cancer detection and treatment response monitoring of multiple tumor types. 会议论文
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), MAY 31-JUN 04, 2019
作者:  Yang, Yang;  Yin, Wei;  Li, Nan;  Xu, Wensheng;  Ma, Fei
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/31

©版权所有 ©2017 CSpace - Powered by CSpace